Evaluation of analgesic efficacy of lidocaine infusion in cesarean sectio
- Conditions
- Cesarean section.Delivery by caesarean section, unspecified
- Registration Number
- IRCT201610023051N11
- Lead Sponsor
- Vice Chancellor for research of Qazvin University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 80
Inclusion criteria : Elective cesarean surgery; patients aged 18 to 45 years, ASA class 1 and 2.
Exclusion criteria: complete heart block; Severe bleeding and coagulation disorder; Severe hypotension and shock; septicemia; history of CNS disease; hyperthyroidism; hypertension; history of hepatorenal disease; Cardiovascular disease; diabetes; Allergy to lidocaine; placenta praevia; Placental abruption; cesarean induced deceleration Fetal heart rate (FHR); meconium; addict; contradiction of regional analgesia; eclampsia and preeclampsia; user of Beta blocker and glycoside.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time to first analgesic requirement. Timepoint: During 24 hrs after the surgery. Method of measurement: Hour.;Sensory block level and recovery of sensory block to T10. Timepoint: 30 and 60 seconds after injection. Method of measurement: Pin prick method.;Motor block level and recovery of motor block. Timepoint: 30 and 60 seconds after injection. Method of measurement: Bromage scale.;Hemodynamic changes (bradycardia, hypotension and Oxygen saturation <90] ). Timepoint: From the time of intervention; every 5 minute until 15 minute then every 15 minute until 1 hour. Method of measurement: Monitoring devise.
- Secondary Outcome Measures
Name Time Method Secondary effects. Timepoint: During 6 hrs after the surgery. Method of measurement: According patient's history.;Neonate APGAR. Timepoint: In the first and fifth minute from birth. Method of measurement: APGAR criteria.